关注
Joyce Chong
标题
引用次数
引用次数
年份
Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer’s disease: a focused review on recent advances
JR Chong, NJ Ashton, TK Karikari, T Tanaka, M Schöll, H Zetterberg, ...
Journal of Neurology, Neurosurgery & Psychiatry 92 (11), 1231-1241, 2021
672021
Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration
YL Chai, JR Chong, J Weng, D Howlett, A Halsey, JH Lee, J Attems, ...
Brain pathology 29 (1), 63-74, 2019
612019
Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment
YL Chai, JR Chong, AR Raquib, X Xu, S Hilal, N Venketasubramanian, ...
Scientific reports 11 (1), 4010, 2021
582021
APOE and cortical superficial siderosis in CAA: Meta-analysis and potential mechanisms
A Charidimou, HI Zonneveld, S Shams, K Kantarci, A Shoamanesh, ...
Neurology 93 (4), e358-e371, 2019
562019
Novel pathophysiological markers are revealed by iTRAQ-based quantitative clinical proteomics approach in vascular dementia
A Datta, J Qian, R Chong, RN Kalaria, P Francis, MKP Lai, CP Chen, ...
Journal of proteomics 99, 54-67, 2014
452014
Plasma P‐tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant …
JR Chong, NJ Ashton, TK Karikari, T Tanaka, FN Saridin, A Reilhac, ...
Alzheimer's & Dementia 17 (10), 1649-1662, 2021
442021
Low plasma ergothioneine levels are associated with neurodegeneration and cerebrovascular disease in dementia
LY Wu, IK Cheah, JR Chong, YL Chai, JY Tan, S Hilal, H Vrooman, ...
Free Radical Biology and Medicine 177, 201-211, 2021
352021
Increased phosphorylation of collapsin response mediator protein-2 at Thr514 correlates with β-amyloid burden and synaptic deficits in Lewy body dementias
H Xing, YA Lim, JR Chong, JH Lee, D Aarsland, CG Ballard, PT Francis, ...
Molecular brain 9, 1-12, 2016
312016
Mitochondrial translocase of the outer membrane alterations may underlie dysfunctional oxidative phosphorylation in Alzheimer’s disease
YL Chai, H Xing, JR Chong, PT Francis, CG Ballard, CP Chen, MKP Lai
Journal of Alzheimer's Disease 61 (2), 793-801, 2018
302018
Increased transforming growth factor β2 in the neocortex of Alzheimer’s disease and dementia with lewy bodies is correlated with disease severity and soluble Aβ 42 load
JR Chong, YL Chai, JH Lee, D Howlett, J Attems, CG Ballard, D Aarsland, ...
Journal of Alzheimer's Disease 56 (1), 157-166, 2017
272017
Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer’s disease and vascular cognitive impairment
XY Chua, YL Chai, WS Chew, JR Chong, HL Ang, P Xiang, K Camara, ...
Alzheimer's Research & Therapy 12, 1-12, 2020
262020
Low plasma ergothioneine predicts cognitive and functional decline in an elderly cohort attending memory clinics
LY Wu, CN Kan, IK Cheah, JR Chong, X Xu, H Vrooman, S Hilal, ...
Antioxidants 11 (9), 1717, 2022
222022
Brain atrophy and white matter hyperintensities are independently associated with plasma neurofilament light chain in an Asian cohort of cognitively impaired patients with …
JR Chong, S Hilal, NJ Ashton, TK Karikari, A Reilhac, H Vrooman, ...
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 15 (1 …, 2023
152023
Head‐to‐head comparison of amplified plasmonic exosome Aβ42 platform and single‐molecule array immunoassay in a memory clinic cohort
T Tanaka, JC Ruifen, YH Nai, CH Tan, CZJ Lim, Y Zhang, ...
European journal of neurology 28 (5), 1479-1489, 2021
142021
Elevation of inactive cleaved annexin A1 in the neocortex is associated with amyloid, inflammatory and apoptotic markers in neurodegenerative dementias
XY Chua, JR Chong, AL Cheng, JH Lee, C Ballard, D Aarsland, ...
Neurochemistry International 152, 105251, 2022
122022
Sphingolipidomics analysis of large clinical cohorts. Part 1: technical notes and practical considerations
WS Chew, WL Seow, JR Chong, MKP Lai, F Torta, MR Wenk, DR Herr
Biochemical and biophysical research communications 504 (3), 596-601, 2018
112018
Sphingolipidomics analysis of large clinical cohorts. Part 2: Potential impact and applications
JR Chong, P Xiang, W Wang, T Hind, WS Chew, WY Ong, MKP Lai, ...
Biochemical and biophysical research communications 504 (3), 602-607, 2018
112018
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers
LL Gibson, C Abdelnour, J Chong, C Ballard, D Aarsland
Current Opinion in Neurology 36 (4), 264-275, 2023
102023
Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer’s disease but not Lewy body dementias
YL Chai, JH Lee, JR Chong, C Ballard, PT Francis, BK Kennedy, ...
Journal of Neuroinflammation 20 (1), 111, 2023
82023
Elevated soluble tnf-receptor 1 in the serum of predementia subjects with cerebral small vessel disease
KHT Salai, LY Wu, JR Chong, YL Chai, B Gyanwali, C Robert, S Hilal, ...
Biomolecules 13 (3), 525, 2023
52023
系统目前无法执行此操作,请稍后再试。
文章 1–20